Phage Display

Struggling with monoclonal antibody development? AtaGenix offers phage display custom services to streamline the process and deliver high-quality antibodies in less than 2 months. Our solutions address challenges like immunogenicity and complex humanization by providing direct access to human monoclonal antibodies. With the world’s first immune phage display library derived from human cancer patient donors and diverse naïve libraries featuring Fab, scFv, and VHH formats, we ensure unmatched diversity and efficiency.

AtaGenix guarantees at least three high-affinity binders tailored for applications such as ELISA, WB, or Flow Cytometry. Backed by extensive expertise and a proven track record, we are leaders in therapeutic, research, and diagnostic antibody development. Partner with us for innovative solutions and accelerated project success.

Rapid Turnaround

Get your antibodies in <2 months
Binding Guaranteed

At least 3 high-affinity binders
Proven Expertise

Benefit from our vast experience with over 500 successful phage display projects

Phage Display Technology Roadmap

A streamlined antibody development workflow, from immune library construction to functional validation. Designed for high diversity, precise screening, and rigorous testing, ensuring stable and effective antibody candidates for research, therapy, or diagnostics.

Step 1: Immune Library Construction

Isolation of relevant immune cells (e.g., PBMC or B cells)
Construction of an scFv, Fab, or other antibody format library

Milestone: Library diversity > 10⁹

Step 2: Antibody Screening

Enrichment via phage display or other display technologies
Identification of high-affinity binders using specific targets
Competitive ELISA or equivalent assays

Milestone: Selection of cross-reactive binders

Step 3: Recombinant Expression

Expression of selected binders in mammalian or bacterial systems
Characterization of binder bioactivity and stability

Milestone: Stable and active antibody candidates

Step 4: Functional Validation

Screening for neutralizing or binding activity
Validation through in vitro and in vivo assays

Milestone: Identification of lead candidates

By Method

By Application

Phage Display

Phage Display Technology Roadmap

Step 1: Immune Library Construction

Step 2: Antibody Screening

Step 3: Recombinant Expression

Step 4: Functional Validation

More Featured Antibody Services

Featured Services

Ask us

About us

Core Technologies

Resource Center